
 
 
 
 
 
 
 
 
   
 1. A process for the preparation a compound of the formula R8 N R9 4 o O R2 R4 m i R5() E Dn C H F O CH2R6 R7 in which RI-R 9 represent, independently of each other hydrogen or a substituent; m is 0, 1 or2; nis0, 1,2or3; and the bonds marked with A, B, C, D, E and F indicate, independently of each other, that two adjacent carbon atoms are connected by a double bond, a single bond, a single bond and a epoxide bridge of the formula H 0 H or a single bond and a methylene bridge of the formula H 2 H C H including, where applicable, an E/Z isomer, a mixture of E/Z isomers, and/or a tautomer thereof, in each case in free form or in salt form, WO 01/36434 PCT/EPOO/ 1139 47 which process comprises 1) bringing a compound of the formula 0 HO O04 O R2 R1 B 3 0~~~0 R4 o 0 O m O A O n m O R5 ED O O mH IF OCH 2R 6 R7 wherein Rr-R7, m, n, A, B, C, D, E and F have the same meanings as given for formula (1) above, into contact with a biocatalyst that is capable of specifically oxidising the alcohol at position 4" in order to form a compound of the formula O O R2 R1 B R4 O m O A O n O R5 (l) ED O eO C H F O CHR R7 WO 01/36434 PCT/EPOO/1 1139 48 in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , m, n, A, B, C, D, E and F have the meanings given for formula (I); and 2) reacting the compound of the formula (l1l) with an amine of the formula HN(Rs)R 9 , wherein R 8 and R 9 have the same meanings as given for formula (1), and which is known, in the presence of a reducing agent; and, in each case, if desired, converting a compound of formula (I) obtainable in accordance with the process or by another method, or an E/Z isomer or tautomer thereof, in each case in free form or in salt form, into a different compound of formula (1) or an E/Z isomer or tautomer thereof, in each case in free form or in salt form, separating a mixture of E/Z isomers obtainable in accordance with the process and isolating the desired isomer, and/or converting a free compound of formula (1) obtainable in accordance with the process or by another method, or an E/Z isomer or tautomer thereof, into a salt or converting a salt, obtainable in accordance with the process or by another method, of a compound of formula (1) or of an E/Z isomer or tautomer thereof into the free compound of formula (I) or an E/Z isomer or tautomer thereof or into a different salt.  
 
     
 2. A process for the preparation of a compound of the formula 0 O O R2 00 B 'IkO R1 B 3 R4 O 0 m O R5 (111), ED O O C H 1 F OCH2R 6 R7 WO 01/36434 PCT/EPOO/1 1139 49 in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , m, n, A, B, C, D, E and F have the meanings given for formula (1) of claim 1, which process comprises 1) bringing a compound of the formula HO 0 0 O R2 R1 B 3 R4 m 0 - ~En D o eO C H F O CH2R6 R7 wherein R 1 -R 7 , m, n, A, B, C, D, E and F have the same meanings as given for formula (1) above, into contact with a biocatalyst that is capable of specifically oxidising the alcohol at position 4", maintaining said contact for a time sufficient for the oxidation reaction to occur and isolating and purifying the compound of formula (11).  
 
     
 3. A process according to claim 1 for the preparation of a compound of the formula (I), in which n is 1; m is 1; A is a double bond; B is single bond or a double bond, C is a double bond, D is a single bond, E is a double bond, F is a double bond; or a single bond and a epoxy bridge; or a single bond and a WO 01/36434 PCT/EPOO/1 1139 50 methylene bridge; R 1 , R 2 and R 3 are H; R 4 is methyl; R 5 is C-C 1 O-alkyl, C 3 -C 8 -cycloalkyl or C 2 -C 10 -alkenyl; R 6 is H; R 7 is OH; R 8 and R 9 are independently of each other H; C-C 1 o-alkyl or C-C 10 -acyl; or together form -(CH 2 )q-; and q is 4, 5 or 6.  
 
     
 4. A process according to claim 1 for the preparation of a compound of the formula (1), in which n is 1; m is 1; A, B, C, E and F are double bonds; D is a single bond; R 1 , R 2 , and R 3 are H; R4 is methyl; R 5 is s-butyl or isopropyl; RN is H; R 7 is OH; R 8 is methyl R 9 is H.  
 
     
 5. A process according to claim 1 for the preparation of 4"-deoxy-4"-N-methylamino avermectin B/B1b benzoate salt.  
 
     
 6. A process according to claim 1 or 2, wherein the biocatalyst is a microorganism.  
 
     
 7. A process according to claim 1 or 2, wherein the biocatalyst is selected from the group consisting of a) a living microorganism in the form of vegetative cells, resting cells or freeze dried cells, b) a dead microorganism, preferably in a partially disintegrated form, that is to say with the cell wall/cell membrane mechanically or chemically or by spray drying permeabilized, WO 01/36434 PCT/EPOO/1 1139 51 c) crude extracts of the cell contents of the said microorganism, d) an enzyme that converts the compounds of the formula (11) into compounds of formula (Ill), and e) the spores of a microorganism.  
 
     
 8. A process according to claim 3 or 4, wherein the microorganism is a representative of the genus Streptomyces.  
 
     
 9. A process according to claim 8, wherein the microorganism is a Streptomyces strain selected from the group consisting of Streptomyces tubercidicus; Streptomyces chattanoogensis, Streptomyces lydicus, Streptomyces saraceticus and Streptomyces kasugaensis.  
 
     
 10. A process according to claim 9 wherein the microorganism is the strain Streptomyces R 922 deposited under accession number DSM-1 3136.  
 
     
 11. A process according to claim 9 wherein the microorganism is the strain Streptomyces I 1529 deposited under accession number DSM-1 3135.  
 
     
 12. A process to produce a compound of formula (111) which comprises the following steps (1) production of cells by inoculation of a nutrient media promoting cell growth with precultures of a microorganism capable of converting a compound of formula (II) to a compound of formula (Ill; (2) harvesting of the cells after growth (3) dissolving a compound of formula (II), in an appropriate solvent (4) addition of the solution from step (3) to a reaction medium which does not promote cell proliferation (5) addition of cells from step (2) to the reaction medium from step (4) (6) shaking or stirring of the reaction mixture of step (5) in the presence of air (7) separation of the cells from the medium (8) extraction of the supernatant and of the cells with appropriate solvents (9) concentration of the organic solvent phases from step (8) WO 01/36434 PCT/EPOO/11139 52 (10) purification of a compound of formula (ll) contained in the extract (9) by chromatography or crystallisation  
 
     
 13. A process to produce a compound of formula (Ill) which comprises the following steps: (1) dissolving a compound of formula (11) in an appropriate solvent (2) addition of the solution from step (1) to a nutrient media promoting cell growth (3) inoculation of the nutrient media of step (2) with precultures of a microorganism capable of converting a compound of formula (11) to a compound of formula (Ill); (4) cultivation of a microorganism capable of converting a compound of formula (II) to a compound of formula (Ill); (5) separation of the cells from the medium (6) extraction of the supernatant and of the cells with appropriate solvents (7) concentration of the organic solvent phases from step (6) in vacuo (8) purification of a compound of formula (Ill) contained in the extract (7) by chromatography or crystallisation.  
 
     
 14. A process according to claims 12 or 13, wherein the compound of formula (II) is avermectin and the compound of formula (Ill) is 4"-oxo-avermectin. 
 
   
 
 
 
 
 
 
 
 
